Tenderwize
Retour à la recherche

Framework agreement for Aflibercept supply

AZ Sint-Lucas vzw·Brugge, Belgium·EUR 5.8M·Expired · Jul 31, 2026·Open·Supplies·Framework
High valueStructured notice only
Titre original de l'avis

Belgium – Various medicinal products – Raamovereenkomst voor de levering van Aflibercept

65/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkExpired
Pourquoi ce score ?

Opportunité

65 / 100

Complexité

60 / 100

Facteurs de risque

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AZ Sint-Lucas vzw
Pays
Belgique
CPV
33690000 - Various medicinal products
Date limite
Jul 31, 2026
Valeur estimée
EUR 5.8M

Aperçu

Moderate opportunity

Faits clés

  • EUR 5.8M estimated value
  • Framework procurement
  • Supplies contract
  • 3 lots
  • Duration until Sep 2030
  • Supply of Aflibercept (40mg/1ml) medicinal products in two forms: prefilled syringes and vials.
  • Three lots corresponding to different product forms and therapeutic indications.
Afficher le résumé complet

This is an open tender from AZ Sint-Lucas vzw in Belgium for the supply of Aflibercept (40mg/1ml) medicinal product. It is divided into three lots: Lot 1 covers prefilled syringes for multiple ophthalmic indications, Lot 2 covers prefilled syringes for retinopathy of prematurity (ROP), and Lot 3 covers vials. Each lot is a framework agreement with a 2-year initial term and two silent 1-year extensions. The total maximum framework value across all lots is EUR 5,803,284 (from XML notice). Award is based primarily on price (82-87%) with quality subcriteria. Electronic submission is required through publicprocurement.be. The tender language is Dutch only. Key risks include short submission window, strict eligibility criteria (financial standing, FAGG license, ESPD), and potential inconsistencies in EU funding status. Procurement documents were not analyzed.

Risques

Lot 1 requires Creditsafe score A, B, or C. Bidders without a good financial score will be excluded. The buyer checks t...

Lot 2 requires a valid FAGG license for distribution. Bidders without this license cannot bid on Lot 2.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Administrative

  • Submission language: Dutch only.
  • Electronic submission via publicprocurement.be is mandatory.
  • Bidders can submit for up to 3 lots.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 2

Price (82%) — 82%Flexibility of storage conditions (8%) — 8%Ease of use and safety (5%) — 5%Production place (5%) — 5%

Lot 3

Price (87%) — 87%Flexibility of storage conditions (8%) — 8%Production place (5%) — 5%

Acheteur

Localisation

Brugge, BEL

Profil acheteur

Ouvrir le profil

Identifiant

408.116.216

Activité

Health

Lots (3)

LOT-0001

Aflibercept Pre-filled Syringe – Multiple Indications

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for: neovascular age-related macular degeneration, visual impairment due to macular edema secondary to retinal vein occlusion, diabetic macular edema, and myopic choroidal neovascularization.

SuppliesFrameworkEU fundedElectronic submission

EUR 5.7M

Valeur estimée

Localisation

Brugge, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Medicinal products

Critères d'attribution

Price

Date limite

Expired Jul 31, 2026

LOT-0002

Aflibercept Pre-filled Syringe – ROP

Supply of Aflibercept (40mg/1ml) prefilled syringe registered for the treatment of retinopathy of prematurity (ROP).

SuppliesFrameworkEU fundedElectronic submission

EUR 8.5k

Valeur estimée

Localisation

Brugge, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Medicinal products

Critères d'attribution

Price

Date limite

Expired Jul 31, 2026

LOT-0003

Aflibercept Vial

Supply of Aflibercept (40mg/1ml) in vial form.

SuppliesFrameworkEU fundedElectronic submission

EUR 98.4k

Valeur estimée

Localisation

Brugge, Belgium

Durée

Sep 2026 - Sep 2030

Catégorie

Medicinal products

Critères d'attribution

Price

Date limite

Expired Jul 31, 2026

Détails de la procédure

Date de publication
01 Jul 2026
Langues
Dutch

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
455937-2026

Documents (2)

Appels d'offres similaires